跳至主要内容
临床试验/NCT03408171
NCT03408171已完成不适用

19-Gauge Fine Needle Aspirate (FNA) Versus 19-Gauge Fine Needle Biopsy (FNB) Needles for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Randomized Prospective Trial

Geisinger Clinic2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Pre-processing Length of the Longest Piece (LLP)

研究概览

简要总结

Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiology and stage of LD. Percutaneous liver biopsy (PLB), transjugular liver biopsy (TLB) and surgical liver biopsy (SLB) are alternative methods for obtaining hepatic tissue. In recent years endoscopic ultrasound guided-liver biopsy (EUS-LB) has come to the forefront as a safe and effective method for obtaining tissue in CLD. There are several studies of the safety of EUS-LB as well as the adequacy of specimens obtained in this fashion. Most studies involve a 19-g needle, therefore in this study we hope to compare the tissue yields of a 19-g fine needle biopsy (FNB) needle, in comparison to conventional 19-g fine needle aspiration (FNA) needle. We predict that 19-g FNA and 19-g FNB needle will demonstrate similar diagnostic accuracy, with less visible blood artifact. Similarly, we predict the safety to be equal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing EUS-LB
  • Platelet count > 50,000
  • International normalized ratio (INR) < 1.5
  • Age > 18 years
  • Non-pregnant patients

排除标准

  • Age < 18 years
  • Pregnant patients
  • Inability to obtain consent
  • Anticoagulants or anti-platelet agents use (excluding aspirin) within the last 7-10 days
  • Platelet count < 50,000
  • Presence of ascites
  • Known liver cirrhosis

结局指标

主要结局

Pre-processing Length of the Longest Piece (LLP)

时间窗: up to 5 days

Pre-processing Length of the longest piece (LLP) measured in centimeter

次要结局

  • Portal Triads Quantity (Median)(3-5 days)
  • Post-processing Length of the Longest Piece (LLP)(3-5 days)
  • Number of Participants With LLP Pre-processing Length Less Than 2 cm or Greater Than 2 cm(3-5 days)
  • Pre-processing Aggregate Specimen Length (ASL)(3-5 days)
  • Post-processing Aggregate Specimen Length (ASL)(3-5 days)
  • Portal Triads Number (Mean)(3-5 days)
  • Number of Participants With Fewer Than 11 Portal Triads or More Than 11 Portal Triads(3-5 days)
  • No. of Fragments > 9 mm, Mean (SD)(3-5 days)
  • Specimen Quality for Histologic Diagnosis(3-5 days)
  • Length of Longest Piece(Number Analyzed)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验